4//SEC Filing
Harrison Seth Loring 4
Accession 0000950170-24-072063
CIK 0001744659other
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 5:22 PM ET
Size
5.2 KB
Accession
0000950170-24-072063
Insider Transaction Report
Form 4
Harrison Seth Loring
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-08+26,000→ 26,000 totalExercise: $23.02Exp: 2034-06-07→ Common Stock (26,000 underlying)
Footnotes (1)
- [F1]This option shall vest in full on the earlier of (i) June 7, 2025, and (ii) the next annual meeting of the Company's stockholders, subject to the director's continued service on the Board.
Documents
Issuer
Akero Therapeutics, Inc.
CIK 0001744659
Entity typeother
Related Parties
1- filerCIK 0001404955
Filing Metadata
- Form type
- 4
- Filed
- Jun 10, 8:00 PM ET
- Accepted
- Jun 11, 5:22 PM ET
- Size
- 5.2 KB